UNIGENE LABORATORIES INC

Inactive Instrument

News Unigene Laboratories Inc

Equities

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Unigene Laboratories Inc : Unigene Announces First Quarter 2013 Financial Results and Provides Corporate Update	13-05-14	PU
Unigene Laboratories Inc : Unigene and Nordic Bioscience Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs	13-05-09	PU
Unigene Laboratories Inc : Victory Park Capital Completes Public Auction of Unigene’s Peptelligence™ Drug Delivery Platform	13-04-17	PU
Unigene Laboratories : Unigene Secures Financing to Extend Operating Runway in Conjunction with Strategic Reorganization – Victory Park Capital Commences Process for Potential Sale of PeptelligenceTM Drug Delivery Platform	13-04-08	PU
Unigene Laboratories Inc : Unigene Announces Fourth Quarter and Full-Year 2012 Results	13-03-12	PU
Unigene Laboratories Inc : Unigene Comments on FDA Advisory Committee Review of Salmon Calcitonin	13-03-06	PU
Unigene Laboratories Inc : UNIGENE RECEIVES 2013 DRUG DELIVERY PARTNERSHIPS	13-02-13	PU
Unigene Laboratories Inc : Unigene to Present at the 17th Annual Drug Delivery Partnerships Meeting	13-02-07	PU
Unigene Laboratories Inc : Unigene Completes Financial Statement Amendment	13-01-31	PU
Unigene Laboratories Inc : Unigene Welcomes FDA Advisory Committee Review of Salmon Calcitonin	13-01-15	PU
Unigene Laboratories Inc : Unigene’s Phase 2 Study of Oral PTH for the Treatment of Osteoporosis in Postmenopausal Women Featured in Bone	12-12-12	PU
Unigene Laboratories Inc : Unigene Engages Financial Advisor to Explore Strategic Options and Advance Corporate Objectives	12-12-11	PU
Unigene Laboratories Inc : UNIGENE AND TARIX PHARMACEUTICALS ENTER DEFINITIVE LICENSING AGREEMENT FOR “PEPTELLIGENCE-ENGINEERED” TXA127	12-11-27	PU
Unigene Laboratories Inc : Unigene Announces Third Quarter 2012 Corporate Update	12-11-20	PU
Unigene Laboratories Inc : Unigene to Announce Third Quarter 2012 Financial Results on November 20, 2012	12-11-16	PU
Unigene Laboratories : Unigene’s Licensee, Tarsa Therapeutics, Reports Positive Clinical Data in Phase 2 Study of Oral Calcitonin for Prevention of Postmenopausal Osteoporosis	12-10-16	PU
Unigene Laboratories : Unigene to Target Partnering and Therapeutic Development Opportunities Following Victory Park Capital Debt Financing and Forbearance	12-09-26	PU
Unigene Laboratories : UNIGENE AND TARIX PHARMACEUTICALS REPORT HIGHLY INCREASED ORAL BIOAVAILABILITY OF “PEPTELLIGENCE-ENGINEERED” TXA127	12-09-19	PU
Unigene Laboratories : UNIGENE AND NORDIC BIOSCIENCE ANNOUNCE PRELIMINARY SELECTION OF LEAD COMPOUND FOR TREATING TYPE 2 DIABETES	12-08-15	PU
Unigene Laboratories : Unigene Enters Agreement to Eliminate 1/3 of its Outstanding $67MM Debt	12-06-04	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
Stock
News Unigene Laboratories Inc

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer